Ignite Creation Date:
2024-05-06 @ 4:43 PM
Last Modification Date:
2024-10-26 @ 2:14 PM
Study NCT ID:
NCT05063136
Status:
RECRUITING
Last Update Posted:
2024-02-26
First Post:
2021-09-13
Brief Title:
Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HRHER2- Primary Breast Cancer
Sponsor:
Henan Cancer Hospital
Organization:
Henan Cancer Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Breast Cancer |
Keywords:
| Name | View |
|---|---|
| HR-positive Her2-negative | View |